Normal view
MARC view
Entry Personal Name
001 - CONTROL NUMBER
- control field: 699
003 - CONTROL NUMBER IDENTIFIER
- control field: OSt
005 - DATE AND TIME OF LATEST TRANSACTION
- control field: 20231019103140.0
008 - FIXED-LENGTH DATA ELEMENTS
- fixed length control field: 231019|| aca||aabn | a|a d
040 ## - CATALOGING SOURCE
- Original cataloging agency: OSt
- Transcribing agency: OSt
100 ## - HEADING--PERSONAL NAME
- Personal name: Bassaganya-Riera, Josep
670 ## - SOURCE DATA FOUND
- Source citation: Work cat.: (OSt)194: Leber, Andrew author 694, Exploratory Studies with NX-13: Oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1, 2022-01.